Caribou Biosciences (CRBU) Equity Income (2022 - 2024)
Caribou Biosciences (CRBU) reported Equity Income of -$14000.0 for Q3 2024, down 250.0% year-over-year from $9333.3 in Q4 2023, and up 86.27% on a QoQ basis from -$102000.0 in Q2 2024.
Caribou Biosciences (CRBU) has 3 years of Equity Income data on file, last reported at -$14000.0 in Q3 2024.
- Quarterly Equity Income fell 250.0% year-over-year to -$14000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$125000.0 (down 119.3% YoY) and the FY2023 annual result came in at -$6000.0, up 95.49% from the prior year.
- Equity Income grew to -$14000.0 in Q3 2024 per CRBU's latest filing, from -$102000.0 in the prior quarter.
- Across five years, Equity Income topped out at $31000.0 in Q3 2022 and bottomed at -$102000.0 in Q2 2024.
- The 3-year median for Equity Income is -$14500.0 (2023), against an average of -$25500.0.
- The widest annual swing landed in 2023, when Equity Income jumped 237.5%; it then tumbled 563.64% in 2024.
- Tracing CRBU's Equity Income over 3 years: stood at -$60000.0 in 2022, then soared by 85.0% to -$9000.0 in 2023, then tumbled by 55.56% to -$14000.0 in 2024.
- Per Business Quant, the three latest CRBU Equity Income figures stand at -$14000.0 (Q3 2024), -$102000.0 (Q2 2024), and -$9000.0 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 235,807.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -14,000.00 |
| Jun 30, 2024 | -102,000.00 |
| Dec 31, 2023 | -9,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | -15,000.00 |
| Dec 31, 2022 | -60,000.00 |
| Sep 30, 2022 | 31,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | -88,000.00 |